BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-7.42%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$5.38B
AUM Growth
+$5.38B
(-8.2%)
Cap. Flow
+$102M
Cap. Flow
% of AUM
1.9%
Top 10 Holdings %
Top 10 Hldgs %
41.73%
Holding
223
New
22
Increased
133
Reduced
36
Closed
13
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$21.9M |
| 2 |
Glaukos
GKOS
|
$18.4M |
| 3 |
Arvinas
ARVN
|
$17.4M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$14.4M |
| 5 |
Becton Dickinson
BDX
|
$12.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$75.9M |
| 2 |
Gilead Sciences
GILD
|
$32.8M |
| 3 |
Neurocrine Biosciences
NBIX
|
$22.3M |
| 4 |
Teladoc Health
TDOC
|
$20M |
| 5 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$15.8M |
Sector Composition
| 1 | Healthcare | 94.28% |
| 2 | Industrials | 0.53% |
| 3 | Technology | 0.51% |
| 4 | Financials | 0.07% |
| 5 | Consumer Discretionary | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOV
51
DELISTED
Myovant Sciences Ltd.
MYOV
| $25M | 0.47% | 4,815,109 +905,000 | +23% | +$4.71M |
|
|
ABMD
52
DELISTED
Abiomed Inc
ABMD
| $23.7M | 0.44% | 133,031 -1,651 | -1% | -$294K |
|
|
AMED
53
DELISTED
Amedisys
AMED
| $23M | 0.43% | 175,658 +1,348 | +0.8% | +$177K |
|
54
Evolent Health
EVH
$1.12B
| $21.8M | 0.4% | 3,025,022 +676,022 | +29% | +$4.86M |
|
55
Qiagen
QGEN
$10.1B
| $21.1M | 0.39% | 638,943 -105,570 | -14% | -$3.48M |
|
56
Insmed
INSM
$28.8B
| $21M | 0.39% | 1,191,480 +571,021 | +92% | +$10.1M |
|
|
HRC
57
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $20.9M | 0.39% | 198,762 -34,436 | -15% | -$3.62M |
|
58
Teleflex
TFX
$5.59B
| $20.1M | 0.37% | 59,114 +22,348 | +61% | +$7.59M |
|
59
LivaNova
LIVN
$3.08B
| $20M | 0.37% | 271,314 +5,648 | +2% | +$417K |
|
60
Zimmer Biomet
ZBH
$21B
| $19.8M | 0.37% | 144,373 +43,174 | +43% | +$5.93M |
|
61
Scholar Rock
SRRK
$3.14B
| $19.7M | 0.37% | 2,197,100 +245,261 | +13% | +$2.2M |
|
|
ITCI
62
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $19.3M | 0.36% | 2,588,990 +343,490 | +15% | +$2.57M |
|
|
63
Arvinas
ARVN
$568M
| $17.4M | 0.32% | +806,403 | New | +$17.4M |
|
64
Thermo Fisher Scientific
TMO
$186B
| $16.7M | 0.31% | 57,236 +212 | +0.4% | +$61.7K |
|
|
WMGI
65
DELISTED
Wright Medical Group Inc
WMGI
| $16.6M | 0.31% | 804,291 +325,796 | +68% | +$6.72M |
|
|
GTHX
66
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $16.4M | 0.31% | 721,925 +50,000 | +7% | +$1.14M |
|
67
CareDx
CDNA
$727M
| $16.3M | 0.3% | 722,655 +230,647 | +47% | +$5.21M |
|
68
Globus Medical
GMED
$8.27B
| $15.2M | 0.28% | 297,666 +24,184 | +9% | +$1.24M |
|
69
Inspire Medical Systems
INSP
$2.77B
| $14.9M | 0.28% | 243,457 +49,117 | +25% | +$3M |
|
70
Insulet
PODD
$23.9B
| $14.7M | 0.27% | 89,245 +5,999 | +7% | +$989K |
|
|
HMSY
71
DELISTED
HMS Holdings Corp.
HMSY
| $14.2M | 0.26% | 411,972 +13,530 | +3% | +$466K |
|
72
HUTCHMED
HCM
$2.58B
| $13.8M | 0.26% | 788,198 +189,888 | +32% | +$3.32M |
|
|
GNMK
73
DELISTED
GenMark Diagnostics, Inc
GNMK
| $13.7M | 0.26% | 2,267,252 -85,815 | -4% | -$520K |
|
74
iRhythm Technologies
IRTC
$5.46B
| $13.7M | 0.25% | 184,419 +5,571 | +3% | +$413K |
|
75
Integra LifeSciences
IART
$1.18B
| $12.8M | 0.24% | 213,557 +21,824 | +11% | +$1.31M |
|